
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 7, pp. 4045-4055
Closed Access | Times Cited: 51
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 7, pp. 4045-4055
Closed Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 83
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 83
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 2
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 2
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
Yunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104572-104572
Open Access | Times Cited: 31
Yunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104572-104572
Open Access | Times Cited: 31
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 13
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 13
Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules
Bowen Ma, Khadija Shahed Khan, Tongyang Xu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 14, pp. 9779-9789
Open Access | Times Cited: 12
Bowen Ma, Khadija Shahed Khan, Tongyang Xu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 14, pp. 9779-9789
Open Access | Times Cited: 12
EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 10
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 10
Research progress of PROTACs for neurodegenerative diseases therapy
Zhifang Cai, Zunhua Yang, Huilan Li, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107386-107386
Closed Access | Times Cited: 8
Zhifang Cai, Zunhua Yang, Huilan Li, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107386-107386
Closed Access | Times Cited: 8
Modulating the phosphorylation status of target proteins through bifunctional molecules
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
An artificial protein modulator reprogramming neuronal protein functions
Peihua Lin, Bo Zhang, Hongli Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Peihua Lin, Bo Zhang, Hongli Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 4
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 4
Overcoming cancer therapy resistance: From drug innovation to therapeutics
Jinrui Wei, Meng‐Yi Lu, Tian‐Hua Wei, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101229-101229
Closed Access
Jinrui Wei, Meng‐Yi Lu, Tian‐Hua Wei, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101229-101229
Closed Access
Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regions
Wenxue Li, Abhijit Dasgupta, Ka Yang, et al.
Cell (2025)
Closed Access
Wenxue Li, Abhijit Dasgupta, Ka Yang, et al.
Cell (2025)
Closed Access
TogoPhosTAC: A Ready-To-Go and Adaptable Targeted Protein Dephosphorylation System
Po‐Han Chen, Yu-Yu Chen, Dong-Ting Ke, et al.
Research Square (Research Square) (2025)
Closed Access
Po‐Han Chen, Yu-Yu Chen, Dong-Ting Ke, et al.
Research Square (Research Square) (2025)
Closed Access
Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s Disease
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation
Emanuele Fabbrizi, Francesco Fiorentino, Fabrizio Casano, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Emanuele Fabbrizi, Francesco Fiorentino, Fabrizio Casano, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities
Ruixin Ge, Miao Chen, Qingchao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Ruixin Ge, Miao Chen, Qingchao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK)
Zhaozhao Wang, S. Qu, Jiahao Yuan, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117514-117514
Closed Access | Times Cited: 9
Zhaozhao Wang, S. Qu, Jiahao Yuan, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117514-117514
Closed Access | Times Cited: 9
TAC‐tics for Leveraging Proximity Biology in Drug Discovery
Dhanusha A. Nalawansha, Kyle Mangano, Willem den Besten, et al.
ChemBioChem (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 9
Dhanusha A. Nalawansha, Kyle Mangano, Willem den Besten, et al.
ChemBioChem (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 9
Proximity-Induced Pharmacology for Amyloid-Related Diseases
Andrea Bertran-Mostazo, Gabrielė Putriūtė, Irene Álvarez-Berbel, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 449-449
Open Access | Times Cited: 3
Andrea Bertran-Mostazo, Gabrielė Putriūtė, Irene Álvarez-Berbel, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 449-449
Open Access | Times Cited: 3
Nanotechnology for tau pathology in Alzheimer's disease
Rongrong Ma, Qianwen Mu, Yue Xi, et al.
Materials Today Bio (2024) Vol. 27, pp. 101145-101145
Open Access | Times Cited: 3
Rongrong Ma, Qianwen Mu, Yue Xi, et al.
Materials Today Bio (2024) Vol. 27, pp. 101145-101145
Open Access | Times Cited: 3
A tau dephosphorylation-targeting chimeraselectively recruits protein phosphatase-1 to ameliorate Alzheimer’s disease and tauopathies
Yue Xiao, Linyu Wei, Jingfen Su, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 3
Yue Xiao, Linyu Wei, Jingfen Su, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 3